Pharma News

NHS rolls out monoclonal antibody treatment for rare bone disease  

Medicenna Presents Preclinical Data on MDNA11 and Bizaxofusp at the 2024 Annual Meeting of the Society for Neuro-Oncology (SNO)

Novartis and Ratio enter radiotherapeutics partnership worth $745m

GSK gains approval in Japan for extended indication of RSV vaccine

Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results

Revealed: The little-known cancer that's surged by 85% in young people...and one alarming reason why

Amneal Pharmaceuticals has submitted another new drug application (NDA) for its dihydroergotamine (DHE) prefilled syringe autoinjector to treat tough-to-treat headaches, after being pr...

The U.S. Food and Drug Administration has approved BridgeBio's, opens new tab drug for a rare and deadly heart condition, the company said on Friday, making it the first new treatment in a market ...

ROME Therapeutics Debuts First Preclinical Data of its LINE-1 Reverse Transcriptase (RT) Inhibitors in Neurodegenerative Diseases at 3rd Annual Dark Genome Symposium

The request is based on findings from the Phase III ASTRO study, which achieved the primary endpoint of clinical remission at week 12. Ulcerative colitis is inflammation of the lower end of the digest...

Reuters - U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co, opens new tab may be linked to serious mental health problems for some patients, ac...

On the heels of positive Phase 2 clinical trial data, Vir Biotechnology is planning for the 2025 launch of a Phase 3 program, dubbed ECLIPSE, to test its treatment combination of tobevibart and elebsi...